Jun 9, 2026 06:47AM
Jun 8, 2026 07:31AM
Jun 3, 2026 06:42AM
May 12, 2026 05:28PM
Apr 28, 2026 06:10AM
Mar 26, 2026 06:48AM
Mar 24, 2026 10:50AM William Blair on Neurogene (NGNE): dosing update further de-risks NGN-401 profile
Mar 24, 2026 10:28AM
Jan 26, 2026 07:50AM
Jan 12, 2026 07:57AM
Jan 12, 2026 07:00AM
Dec 17, 2025 05:28AM
Nov 14, 2025 07:26AM
Nov 13, 2025 09:45AM Stifel Reiterates Buy Rating on Neurogene (NGNE)
Nov 13, 2025 06:44AM
Oct 9, 2025 07:01AM
Oct 3, 2025 06:43AM
Aug 14, 2025 08:01AM
Aug 11, 2025 05:01PM
Jul 1, 2025 08:21AM
Jun 30, 2025 04:02PM Neurogene (NGNE) Announces Registrational Trial Design for Embolden Study of NGN-401 Gene Therapy
Jun 17, 2025 09:17AM
Jun 11, 2025 04:02PM
Jun 5, 2025 12:44PM
May 29, 2025 08:58AM
May 19, 2025 12:29PM
May 16, 2025 07:01AM
May 16, 2025 03:35AM Baird Downgrades Neurogene (NGNE) to Neutral
Apr 14, 2025 05:05AM
Apr 2, 2025 04:01PM
Mar 26, 2025 07:05AM
Mar 24, 2025 04:38PM
Nov 25, 2024 06:47AM
Nov 20, 2024 04:54PM
Nov 19, 2024 04:02PM Neurogene (NGNE) PT Lowered to $45 at BMO Capital
Nov 19, 2024 11:07AM
Nov 19, 2024 03:50AM
Nov 18, 2024 06:45AM
Nov 12, 2024 09:09AM
Nov 12, 2024 09:09AM
Nov 12, 2024 07:16AM
Nov 12, 2024 06:57AM Neurogene (NGNE) PT Raised to $55 at H.C. Wainwright
Nov 11, 2024 04:51PM
Nov 11, 2024 04:01PM
Nov 4, 2024 07:32AM
Oct 16, 2024 07:53AM
Aug 14, 2024 10:14AM
Aug 12, 2024 06:52AM
Aug 7, 2024 07:30AM Neurogene (NGNE) Receives RMAT Designation for NGN-401
Jul 12, 2024 07:49AM

413,645 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All